Omega-3 Bioavailability From Vegetable-omega-3 Enriched Products

Status Recruiting

Clinical Trial Summary

CSIRO's Food Program has developed a novel vegetable-based Omega-3 long-chain polyunsaturated fatty acid (Omega 3)encapsulant to be used as ingredient in various food products, however, it is unknown whether the vegetable-based carrier matrix will affect omega-3 bioavailability. This project aims to compare the bioavailability of omega-3 from two test foods containing vegetable (cauliflower)-encapsulated algal oil (the "ingredient") against a control test product (algal oil gel capsules) across two ethnicities (Australian European vs. Chinese Singaporean).

Clinical Trial Description

Omega-3 long-chain polyunsaturated fatty acids (omega-3) (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) is associated with many health benefits including improved brain, heart, joint and eye health. However, <20% of the world's population consume adequate amounts of these fatty acids. Individuals who don't consume fish (major dietary omega-3 source) and particularly vegans/vegetarians are at greatest risk of omega-3 deficiency. Convenient strategies empowering consumers to increase their omega-3 intake have potential to significantly impact health outcomes. CSIRO's Food Program has developed a novel vegetable-based omega-3 encapsulant to be used as ingredient in various food products. Using algal oil as omega-3 source provides vegan/vegetarian options. However, it is unknown whether the vegetable-based carrier matrix will affect omega-3 bioavailability. As these products are intended for global markets, it is also unknown whether ethnic differences may affect omega-3 bioavailability. This project forms part of a larger project aiming to develop sensorially and culturally acceptable food products that incorporate vegetable-encapsulated omega-3 oils to assist Australian and Singaporean consumers to achieve their omega-3 LCPUFA intake. This component of the project aims to compare the bioavailability of omega-3 from two test foods containing vegetable (cauliflower)-encapsulated algal oil (the "ingredient") against a control test product (algal oil gel capsules) across two ethnicities (Australian European vs. Chinese Singaporean). To achieve this, two clinical trials, following the same protocol, will be executed in both Australia (Australian European) and Singapore (Chinese Singaporean). ;

Study Design

Related Conditions & MeSH terms

Lifestyle

Clinical Trial Details

NCT number	NCT04610983
Study type	Interventional
Source	Commonwealth Scientific and Industrial Research Organisation, Australia
Contact	Bradley L Klingner, BSc
Phone	+61 8 83038818
Email	Bradley.Klingner@csiro.au
Status	Recruiting
Phase	Phase 2
Start date	November 16, 2020
Completion date	February 2021

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02843269` - Multiple-component Workplace FRamed Intervention to Decrease Occupational Muscle Pain - FRIDOM	N/A
Completed	`NCT01958307` - Healthy Living in Pregnancy	N/A
Completed	`NCT06072742` - Effect of Lifestyle on Caries and Apical Periodontitis
Terminated	`NCT05084274` - Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program	N/A
Not yet recruiting	`NCT06375460` - Real-time Engagement for Learning to Effectively Control Type 2 Diabetes	N/A
Enrolling by invitation	`NCT04314882` - The Danish National Survey of Diet and Physical Activity 2021-2023
Completed	`NCT02736214` - Reproductive Life Plan-based Counseling With Men	N/A
Recruiting	`NCT03711539` - Lifetime Endurance Exercise to Prevent Coronary Artery Disease
Completed	`NCT05264155` - Evaluation of the Impact of Adaptive Goal Setting on Engagement Levels of Government Staff With a Gamified mHealth Tool	N/A
Recruiting	`NCT03242174` - Health Behaviors in Pregnancy
Recruiting	`NCT06248775` - Nursing Prehabilitation Intervention Supported With Technology for Vascular Surgery in People With Type 2 Diabetes	N/A
Completed	`NCT05355038` - Effect of Lifestyle Modification on Pregnancy Outcome for GDM	N/A
Not yet recruiting	`NCT05533749` - Evaluating the Effectiveness of the GILL eHealth Intervention to Improve Physical Health and Lifestyle Behaviours in Patients With Severe Mental Illness	N/A
Not yet recruiting	`NCT05600205` - Evaluation of Combined Support for the Ambulatory Lifestyle Intervention	N/A
Active, not recruiting	`NCT03045237` - Healthy Bellies - Intervention Program During Pregnancy on Women and Newborn	N/A
Completed	`NCT03396029` - Tailored Written Lifestyle Feedback in Colorectal Cancer Screening	N/A
Recruiting	`NCT04411511` - COVID-19, Obesity and Lifestyle in Children
Not yet recruiting	`NCT02648555` - A Lifestyle Intervention to Improve in Vitro Fertilization Results	N/A
Completed	`NCT02786394` - Return to Everyday Activities in the Community and Home	N/A
Completed	`NCT01842061` - Everyday Activity Supports You (EASY) Pilot Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.